e-learning
resources
ERJ
2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis
Ling D. I., Zwerling A. A., Pai M.
Source:
Eur Respir J 2008; 32: 1165-1174
Journal Issue:
November
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ling D. I., Zwerling A. A., Pai M.. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J 2008; 32: 1165-1174
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
GenoType MTBDRsl performance on clinical samples with diverse genetic background},
Source: Eur Respir J 2012; 40: 690-698
Year: 2012
Detection of isoniazid or rifampin resistant
Mycobacterium tuberculosis
in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
Efficacy of treatment of MDR/XDR TB patients based on rapid diagnostics of
M. tuberculosis
drug resistance by
GenoType MTBDRplus and GenoType MTBDRsl (Hain Lifescience GmbH, Germany)
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Line probe assay (LiPA) based rapid detection of multiple drug resistent (MDR) mycobacterium tuberculosis (MTB)
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Detection of M. tuberculosis multi-drug resistance using GenoType® MTBDRplus
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Clinical and operational value of the extensively drug-resistant tuberculosis definition
Source: Eur Respir J 2007; 30: 623-626
Year: 2007
Comparative evaluation of the rapid diagnostic assays for detecting tuberculosis (TB) in a reference center for drug resistant TB in Brazil
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Xpert MTB/RIF assay for rapid detection of Mycobacterium tuberculosis and rifampicin resistance
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms
Source: Eur Respir J 2012; 39: 163-171
Year: 2012
Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms
Source: Eur Respir J 2011; 39: 163-171
Year: 2012
Evaluation of a line probe assay kit for direct and simultaneous detection of mycobacterium tuberculosis complex and its resistance to rifampin
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying
mycobacterium tuberculosis
during routine clinical practice
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Comparision of line probe assay and conventional methos for detection of mycobacteria other than tuberculosis (MOTT) strains from patients suferring from pulmonary tuberculosis
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016
Detection of fluoroquinolones resistance mutations in
mycobacterium tuberculosis
by hydrolysis probes and RFLP
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013
Microbiology of
Mycobacterium tuberculosis
and a new diagnostic test for TB
Source: Eur Respir Mon 2012; 58: 1-13
Year: 2012
Drug-susceptibility testing in tuberculosis: methods and reliability of results
Source: Eur Respir J 2005; 25: 564-569
Year: 2005
Rapid detection of multi-drug-resistant tuberculosis (MDR-TB) in one day using the new molecular-biological test genotype MTBDRÔ
Source: Eur Respir J 2006; 28: Suppl. 50, 290s
Year: 2006
Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay
Source: Eur Respir J 2013; 41: 1163-1171
Year: 2013
Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept